These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35004254)

  • 1. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
    Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
    Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognostic factors of pulmonary carcinosarcoma: A nomogram development and validation based on surveillance epidemiology and end results database.
    Zhang MY; Tang LS; Qin ZJ; Hao YT; Cheng K; Zheng A
    Front Med (Lausanne); 2022; 9():988830. PubMed ID: 36330063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
    Yang J; Yin H; Liu M; Zou G; Yu B
    Front Surg; 2023; 10():1108732. PubMed ID: 36911624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
    Liang M; Chen M; Singh S; Singh S
    Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
    Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
    Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: A population-based respective study in China and the SEER database.
    Liu Y; Yang M; Pang Z; Zhao X; Ma G; Zhao Q; Du J
    Heliyon; 2023 Apr; 9(4):e15319. PubMed ID: 37089398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
    Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
    Front Oncol; 2022; 12():921365. PubMed ID: 36465408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
    Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
    Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for combined small cell lung cancer patients.
    He J; Xu S; Pan H; Li S; He J
    Transl Lung Cancer Res; 2020 Oct; 9(5):1785-1794. PubMed ID: 33209601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling of combined small cell lung cancer.
    Zhang J; Zhang L; Luo J; Ge T; Fan P; Sun L; Hou L; Li J; Yu H; Wu C; Zhu Y; Wu C; Jiang G; Troncone G; Malhotra J; Okuda K; Santarpia M; Zamarchi R; Goto T; Cardona AF; Xu J; Chen Q; Zhang Z; Zhang P;
    Transl Lung Cancer Res; 2021 Feb; 10(2):636-650. PubMed ID: 33718010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
    Zhang S; Xiao X; Qin X; Xia H
    Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis.
    Rong YT; Zhu YC; Wu Y
    Transl Cancer Res; 2022 Dec; 11(12):4289-4302. PubMed ID: 36644187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomogram and novel risk-scoring system for small cell lung cancer with different patterns of metastases.
    Ruan H; Sun H; Guo Y; Ding Y; Liu Y; Ying S; Lin P
    Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1022-1031. PubMed ID: 35716296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
    Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
    J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.